Abstract: A heating, ventilation, and/or air conditioning (HVAC) system in accordance with present embodiments includes a housing, one or more sensing units disposed within the housing, and a controller disposed within the housing. The controller is operable to communicate with the one or more sensing units through a wireless communication link to receive sensed data, and analyze the sensed data by applying one or more data processing techniques.

Abstract: A microcontroller controlled altimeter includes a microcontroller, a digital altitude pressure sensor with a pressure indicating output coupled to the microprocessor, and at least one Form A solid state relay coupled to the microcontroller, where the microcontroller is configured to provide control signals to the at least one Form A solid state relay to provide an open circuit between normally open and common terminals of the at least one Form A solid state relay if the digital altitude pressure sensor output is less than, or equal to, a setpoint for the at least one Form A relay, and provide continuity between the normally open and common terminals of the at least one Form A solid state relay if the digital altitude pressure sensor output is greater than the setpoint for the at least one Form A relay.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: A microcontroller controlled altimeter includes a microcontroller, a digital altitude pressure sensor with a pressure indicating output coupled to the microprocessor, and at least one Form A solid state relay coupled to the microcontroller, where the microcontroller is configured to provide control signals to the at least one Form A solid state relay to provide an open circuit between normally open and common terminals of the at least one Form A solid state relay if the digital altitude pressure sensor output is less than, or equal to, a setpoint for the at least one Form A relay, and provide continuity between the normally open and common terminals of the at least one Form A solid state relay if the digital altitude pressure sensor output is greater than the setpoint for the at least one Form A relay.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: Methods and apparatus for use with gas-filled downhole tools are disclosed herein. A disclosed example method includes opening an isolation valve of a downhole tool, wherein the isolation valve is in fluid communication with first and second ports of the downhole tool, and wherein the first and second ports are in fluid communication with respective first and second ends of an interior cavity of the downhole tool; coupling a source of inert gas to the first port and flowing the inert gas into the interior cavity of the downhole tool to expel air from the interior cavity through the second port; closing the second port when the air is expelled from the interior cavity; and closing the isolation valve to seal the inert gas in the interior cavity.

Abstract: Methods and apparatus for use with gas-filled downhole tools are disclosed herein. A disclosed example method includes opening an isolation valve of a downhole tool, wherein the isolation valve is in fluid communication with first and second ports of the downhole tool, and wherein the first and second ports are in fluid communication with respective first and second ends of an interior cavity of the downhole tool; coupling a source of inert gas to the first port and flowing the inert gas into the interior cavity of the downhole tool to expel air from the interior cavity through the second port; closing the second port when the air is expelled from the interior cavity; and closing the isolation valve to seal the inert gas in the interior cavity.

Abstract: Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines. The present invention refers to pharmaceutically acceptable compounds of Formula I, their salts and derivatives, where (a) and (b) can take any value between 0 and 14, (X) can be substituted by any atom or group of atoms with an atomic/molecular weight between 4 and 200 Da and (R) can be substituted by any atom or group of atoms with an atomic/molecular weight between 1 and 200 Da, for use as medicines.

Abstract: A method of controlling and delaying the inversion of a drilling fluid and the wettability of a filtercake by using a delayed phase changing agent. The filtercake is preferably formed while drilling a subterranean formation using a drilling fluid includes: an oleaginous fluid; a non-oleaginous fluid; an amine surfactant having the structure: wherein R is a C12–C22 aliphatic hydrocarbon; R? is an independently selectable from hydrogen or C1 to C3 alkyl; A is NH or O, and 1?x+y?3. In the method, the filter cake is exposed to a delayed phase changing agent selected from the group consisting of aliphatic amine acids, salts of aliphatic amine acids and combinations thereof. In one preferred illustrative embodiment, the delayed phase changing agent is delivered in the form of a pill, the pill including a carrier fluid, a viscosifier and the delayed phase changing agent.

Abstract: A method of controlling and delaying the inversion of a drilling fluid and the wettability of a filtercake by using a delayed phase changing agent.